ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $2.05 by 7.8 percent. This is a 22.78 percent increase over earnings of $1.80 per share from the same period last year. The company reported quarterly sales of $266.044 million which beat the analyst consensus estimate of $260.128 million by 2.27 percent. This is a 25.87 percent increase over sales of $211.371 million the same period last year.